Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001213900-25-027141
Filing Date
2025-04-01
Accepted
2025-04-01 16:19:23
Documents
14
Period of Report
2024-12-27
Items
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.01: Changes in Control of Registrant
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K/A ea0236574-8ka_180life.htm   iXBRL 8-K/A 66077
  Complete submission text file 0001213900-25-027141.txt   292791

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE atnf-20241227.xsd EX-101.SCH 3762
3 XBRL DEFINITION FILE atnf-20241227_def.xml EX-101.DEF 26612
4 XBRL LABEL FILE atnf-20241227_lab.xml EX-101.LAB 36679
5 XBRL PRESENTATION FILE atnf-20241227_pre.xml EX-101.PRE 25236
16 EXTRACTED XBRL INSTANCE DOCUMENT ea0236574-8ka_180life_htm.xml XML 5925
Mailing Address 3000 EL CAMINO REAL BLDG 4, STE 200 PALO ALTO CA 94306
Business Address 3000 EL CAMINO REAL BLDG 4, STE 200 PALO ALTO CA 94306 650-507-0669
180 Life Sciences Corp. (Filer) CIK: 0001690080 (see all company filings)

EIN.: 813832378 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 001-38105 | Film No.: 25799941
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)